Clinical Research Directory
Browse clinical research sites, groups, and studies.
Precision Care for Major Depressive Disorder
Sponsor: University of California, San Francisco
Summary
This study aims to assess whether phenotyping-guided intervention selection is superior to intervention selection without phenotyping guidance (i.e., routine clinician and patient judgment regarding treatment selection) for depression.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2024-11-12
Completion Date
2029-09-01
Last Updated
2025-09-05
Healthy Volunteers
No
Interventions
Pramipexole
CAU plan modified to include a trial of pramipexole.
Methylphenidate
CAU plan modified to include a trial of methylphenidate (or, if contraindicated: guanfacine).
Phenelzine
CAU plan modified to include a trial of phenelzine (or, if contraindicated: brexpiprazole).
Mindfulness-based Stress Sensitivity Therapy (MBSST)
CAU plan modified to include a trial of MBSST. MBSST is an individual psychotherapy delivered approximately weekly for 16 sessions.
Complicated Grief Treatment (CGT)
CAU plan modified to include a trial of CGT.
Care as usual (CAU) plan
Unmodified CAU plan.
Locations (1)
Nancy Friend Pritzker Psychiatry Building, University of California, San Francisco
San Francisco, California, United States